|
HIF1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.114800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.293000E-01 |
| Normal-vs-Stage2 |
4.482600E-01 |
| Normal-vs-Stage3 |
7.292400E-01 |
| Normal-vs-Stage4 |
2.967600E-01 |
| Stage1-vs-Stage2 |
8.797600E-01 |
| Stage1-vs-Stage3 |
3.311400E-01 |
| Stage1-vs-Stage4 |
6.669400E-01 |
| Stage2-vs-Stage3 |
3.518600E-01 |
| Stage2-vs-Stage4 |
6.393000E-01 |
| Stage3-vs-Stage4 |
2.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.556800E-01 |
| Normal-vs-AfricanAmerican |
7.116800E-01 |
| Normal-vs-Asian |
5.437800E-01 |
| Caucasian-vs-AfricanAmerican |
6.253000E-01 |
| Caucasian-vs-Asian |
4.342400E-01 |
| AfricanAmerican-vs-Asian |
4.912800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.650230E-01 |
| Normal-vs-Female |
3.853800E-01 |
| Male-vs-Female |
1.049850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.793400E-01 |
| Normal-vs-Extreme_Weight |
3.240600E-01 |
| Normal-vs-Obese |
8.601400E-01 |
| Normal-vs-Extreme_Obese |
8.429400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.871800E-01 |
| Normal_Weight-vs-Obese |
3.267800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.118000E-01 |
| Extreme_Weight-vs-Obese |
2.598200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.774400E-01 |
| Obese-vs-Extreme_Obese |
7.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.132600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.047600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.896800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.110200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.757600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.541800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.396000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.914600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.484800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.746800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.441600E-01 |
| Normal-VS-Type2 PRCC |
6.558400E-01 |
| Normal-VS-KIRP CIMP |
9.790600E-01 |
| Normal-VS-Unclassified PRCC |
8.223800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.061200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.904400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.907200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.977400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.570400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.983400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.389170E-01 |
| Normal-vs-N1 |
9.640000E-01 |
| Normal-vs-N2 |
4.056000E-01 |
| N0-vs-N1 |
1.792050E-01 |
| N0-vs-N2 |
8.233800E-01 |
| N1-vs-N2 |
4.536400E-01 |
|
|
